OrthoPediatrics price target lowered to $35 from $50 at Citizens JMP

Citizens JMP analyst David Turkaly lowered the firm’s price target on OrthoPediatrics (KIDS) to $35 from $50 and keeps an Outperform rating on the shares. OrthoPediatrics reported a quarterly record on its top line, though revenues and adjusted EBITDA were shy of consensus, but the company continues to take share in all of its key market segments, and full-year guidance was largely reiterated, the analyst tells investors in a research note. The firm believes the fundamentals around the business remain solid.